Left ventricular wall stress and sarcoplasmic reticulum Ca2+-ATPase gene expression in renal hypertensive rats: Dose-dependent effects of ACE inhibition and AT1-receptor blockade

Cardiovascular Research

Volumn 31, Issue 5, 1996, Pages 758-768

  Zierhut, W ^a   Studer, R ^b   Laurent, D ^a   Kastner S ^b   Allegrini, P ^a   Whitebread, S ^a   Cumin, F ^a   Baum, H P ^a   De Gasparo, M ^a   Drexler, H ^b  

^a CIBA GEIGY LTD   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ACE inhibitors; Angiotensin receptor; Atrial natriuretic factor; Gene expression; Rat, renal hypertensive; Sr Ca ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN 1 RECEPTOR; ATRIAL NATRIURETIC FACTOR; BENAZEPRIL; PLACEBO; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SARCOPLASMIC RETICULUM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATRIAL NATRIURETIC FACTOR; BENZAZEPINES; BLOTTING, NORTHERN; CALCIUM-TRANSPORTING ATPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; HYPERTENSION, RENAL; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; SARCOPLASMIC RETICULUM; TETRAZOLES; VALINE;

EID: 0029884534     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00019-3     Document Type: Article

References (45)

1. Kannel WB, Abbott RD. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham study. Am Heart J 1986;111:391-397.
2. Mann DL, Kent RL, Cooper G, IV. Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ Res 1989;64:1079-1090.
3. Cooper G, IV, Kent RL, Mann DL. Load induction of cardiac hypertrophy. J Mol Cell Cardiol 1989;21(Suppl V):11-30.
4. Morgan HE, Baker KM, Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991;83:13-25.
5. Zierhut W, Zimmer H-G. Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 1989;65:1417-1425.
6. Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg EO, Izumo S, Riegger G, Lorell B. Angiotensin II-induced growth responses in isolated adult rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 1995;76:489-497.
7. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system. Circ Res 1991;68:905-921.
8. Rogers TB, Gaa ST, Allen IS. Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmacol Exp Ther 1986;236:438-444.
9. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977-984.
10. Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990;259:H324-H332.
11. Linz W, Schölkens BA, Ganten D. Converting enzyme inhibition prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exper Hyperten - Theory Practice 1989;A11:1325-1350.
12. Linz W, Schölkens BA. Bradykinin receptor antagonist abolishes the antihypertrophic effect of ramipril. In: Bönner G, Schölkens BA, Scicli AG, eds. The Role of Bradykinin in the Cardiovascular Action of Ramipril. Wiesbaden: Media Medica, 1991:85-90.
13. Rhaleb N-E, Yang X-P, Scicli AG, Carretero OA. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension 1994;23(2):865-868.
14. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 1994;23:411-418.
15. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 1993;73:184-192.
16. 2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 1990;66:554-564.
17. 2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum: regulation of its expression by pressure overload and developmental stage. J Clin Invest 1989;83:1102-1108.
18. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H. Relationship between myocardial function and expression of sarcoplasmic reticulum calcium-ATPase in failing and nonfailing human myocardium. Circ Res 1994;75:434-442.
19. Rudin M, Pedersen B, Umemura K, Zierhut W. Determination of rat heart morphology and function in vivo in two models of cardiac hypertrophy by means of magnetic resonance imaging. Basic Res Cardiol 1991;86:165-174.
20. Manning WJ, Wei JY, Fossel ET, Burstein D. Measurement of left ventricular mass in rats using electrocardiogram-gated magnetic resonance imaging. Am J Physiol 1990;258:H1181-H1186.
21. Wood J, Mah SC, Baum HP, de Gasparo M, Cumin F, Rüeger H, Nussberger J. Evaluation of a potent inhibitor of subprimate and primate renins. J Pharmacol Exp Ther 1990;253:513-517.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Rosen KM, Lamperti ED, Villa-Komaroff L. Optimizing the Northern blot procedure. BioTechniques 1990;8:398-403.
24. 2+-ATPase mRNA. FEBS Lett 1989;249:35-41.
25. Seidman CE, Duby AD, Choi E, Graham RM, Haber E, Homey C, Smith JA, Seidman JG. The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. Science 1984;225:324-326.
26. Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW. Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta-and gamma-actin genes using specific cDNA probes. Cell 1980;20:95-105.
27. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994;89:2273-2282.
28. Rockman HA, Wachhorst SP, Mao L, Ross J. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 1994;266:H2468-H2475.
29. Kojima M, Shiojima I, Yamazaki T, et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994;89:2204-2211.
30. Everett AD, Tufro-McReddie A, Fischer A, Gomez RA. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-β1 expression. Hypertension 1994;23:587-592.
31. Linz W, Henning R, Schölkens BA. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats. J Hypertension 1991;9(Suppl. 6):S400-S401.
32. Ruzicka M, Yuan B, Leenen FHH. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation 1994;90:484-491.
33. Wollert KC, Studer R, von Bülow B, Drexler H. Survival post myocardial infarction in the rat: role of tissue angiotensin-converting enzyme inhibition. Circulation 1994;90:2457-2467.
34. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 1988;85:339-343.
35. Drexler H, Hänze J, Finckh M, Lu W, Just H, Lang RE. Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation 1989;79:620-633.
36. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992;44:479-602.
37. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991;5:3037-3046.
38. Takemura G, Fujiwara H, Horike K, et al. Ventricular expression of atrial natriuretic polypeptide and its relations with hemodynamics and histology in dilated human hearts. Immunohistochemical study of the endomyocardial biopsy specimens. Circulation 1989;80:1137-1147.
39. Bunkenburg B, Schnell CH, Baum H-P, Cumin F, Wood JM. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences. Hypertension 1991;18:278-288.
40. Goldberg MR, Tanaka W, Barchowsky A, et al. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Hypertension 1993;21:704-713.
41. 2+-ATPase in cardiac hypertrophy by angiotensin converting enzyme? Basic Res Cardiol 1992;87(Suppl. 2):191-204.
42. Holtz J, Goetz R, Reinecke H, Studer R. Myocardial phenotype changes in hypertensive cardiac hypertrophy: phenotype normalization with normalization of wall stress in spite of persisting hypertension and hypertrophy. Circulation 1992;86(Suppl. I);I-94 (Abstract).
43. Allgeier J, Goetz RM, Studer R, Reinicke H, Holtz J. Involvement of bradykinin in the cardioreparation by chronic quinapril in rats with hypertensive left ventricular hypertrophy. Circulation 1992;86/4:I-329 (Abstract).
44. Weinberg EO, Schoen FJ, Schoen FJ, et al. ACE inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994;90:1410-1422.
45. Bruckschlegel G, Homer SR, Jandeleit K, Grimm D, Muders F, Kromer E, Riegger GAJ, Schunkert H. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995;25:250-259.